Authors:
Hermann, RM
Krech, R
Hartlapp, J
Esser, E
Christoph, B
Muller, MK
Wagner, W
Citation: Rm. Hermann et al., Evaluation of a qualitative regression grading as a prognostic factor in advanced head and neck cancer after neoadjuvant radiochemotherapy, STRAH ONKOL, 177(6), 2001, pp. 277-282
Authors:
Otterbach, F
Bankfalvi, A
Bergner, S
Decker, T
Krech, R
Boecker, W
Citation: F. Otterbach et al., Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis ofatypical proliferations of the breast, HISTOPATHOL, 37(3), 2000, pp. 232-240
Authors:
Wagner, W
Hermann, R
Hartlapp, J
Esser, E
Christoph, B
Muller, MK
Krech, R
Koch, O
Citation: W. Wagner et al., Prognostic value of hemoglobin concentrations in patients with advanced head and neck cancer treated with combined radio-chemotherapy and surgery, STRAH ONKOL, 176(2), 2000, pp. 73-80
Authors:
Lampe, S
Bohmer, S
Goeschen, K
Krech, R
Gr-Beilage, O
Schulz, J
Citation: S. Lampe et al., The terminal CTG as the expression of a high degree of risk to the child -two case studies, Z GEBU NEON, 203(1), 1999, pp. 39-43
Authors:
Bankfalvi, A
Ofner, D
Schmid, KW
Schmitz, KJ
Breukelmann, D
Krech, R
Bocker, W
Citation: A. Bankfalvi et al., Standardized in situ AgNOR analysis in breast pathology: Diagnostic and cell kinetic implications, PATH RES PR, 195(4), 1999, pp. 219-229
Authors:
Bankfalvi, A
Terpe, HJ
Breukelmann, D
Bier, B
Rempe, D
Pschadka, G
Krech, R
Lelle, RJ
Boecker, W
Citation: A. Bankfalvi et al., Immunophenotypic and prognostic analysis of E-cadherin and beta-catenin expression during breast carcinogenesis and tumour progression: a comparativestudy with CD44, HISTOPATHOL, 34(1), 1999, pp. 25-34
Authors:
Muller, T
Schafer, H
Rodeck, B
Haupt, G
Koch, H
Bosse, H
Welling, P
Lange, H
Krech, R
Feist, D
Muhlendahl, KE
Bramswig, J
Feichtinger, H
Muller, W
Citation: T. Muller et al., Familial clustering of infantile cirrhosis in Northern Germany: A clue to the etiology of idiopathic copper toxicosis, J PEDIAT, 135(2), 1999, pp. 189-196